Bausch + Lomb Corporation BLCO

Bausch + Lomb Corporation es una empresa de salud ocular. Opera a través de tres segmentos: Cuidado de la Visión, Farmacéuticos y Quirúrgico. El segmento de Cuidado de la Visión incluye tanto lentes de contacto como un negocio de cuidado ocular para consumidores que consiste en productos para el cuidado de lentes de contacto, gotas para los ojos de venta libre y vitaminas para los ojos. El segmento Farmacéutico consiste en productos farmacéuticos genéricos para tratamientos postoperatorios y tratamientos para diversas condiciones oculares, como el glaucoma, la inflamación ocular, la hipertensión ocular, los ojos secos y enfermedades retinianas. El segmento Quirúrgico consiste en equipos médicos, consumibles, instrumentos y tecnologías para el tratamiento de cataratas, córneas y condiciones oculares vítreas y retinianas, que incluyen sistemas de entrega, equipos de facoemulsificación y otros instrumentos y dispositivos quirúrgicos para cirugía de cataratas. Sus marcas incluyen PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, y muchas más.

• GlobeNewswire Inc. 24 sept

  Veterinary Ophthalmology Equipment Market by Product, Animal Type, Application, End User, Region Report Forecasts Market to Reach USD 0.83 Billion by 2031, Growing at a 7.7% CAGR

  The global veterinary ophthalmology equipment market is expected to grow from USD 0.57 billion in 2026 to USD 0.83 billion by 2031, at a 7.7% CAGR. Growth is driven by rising pet ownership, increased prevalence of animal eye diseases, and adoption of advanced diagnostic and surgical technologies. Treatment applications and surgical equipment segments are leading growth, with Asia Pacific emerging as the fastest-growing region.

  

• Zacks Investment Research 14 sept

  BLCO Gains European CE Mark for Next-Gen SeeLyra Femtosecond Laser

  Bausch + Lomb (BLCO) announced that its SeeLyra femtosecond laser received European CE Mark approval, expanding its surgical technology portfolio. The platform uses live swept-source OCT for real-time visualization and precise surgical control in cataract, LASIK, and corneal procedures. A limited European launch is planned with broader availability expected in 2027. The global ophthalmic femtosecond lasers market is projected to grow at 7.5% CAGR through 2033.

  

• GlobeNewswire Inc. 2 sept

  Nicox Announces Extension of Cash Runway

  Nicox SA announced an extension of its cash runway to beyond Q1 2028 with €8.4 million in cash as of August 31, 2026. The company expects an FDA approval milestone for NCX 470 by April 30, 2027, which would fund operations into 2029, with subsequent royalties potentially extending visibility further. Management changes include Doug Hubatsch transitioning to Chief Scientific Advisor and Siobhan Garbutt assuming leadership of the development team.

  

• GlobeNewswire Inc. 13 jul

  Ophthalmology Devices Market Report Released, Includes Profiles of EssilorLuxottica, Alcon, Bausch + Lomb, and 20 Others

  The global ophthalmology devices market is projected to grow from $56.61 billion in 2025 to $99.22 billion by 2030, with a CAGR of 11.9%. Key growth drivers include rising demand for minimally invasive surgeries, an aging population, increased eye disorders, and innovation in precision surgical tools. Leading companies include EssilorLuxottica, Alcon, Bausch + Lomb, and HOYA Corporation, with North America currently leading the market while Asia-Pacific shows rapid growth potential.